PRESS RELEASE published on 08/06/2024 at 09:42, 1 year 8 months ago USU Achieves SAP® Certified Integration with RISE with SAP S/4HANA® Cloud USU Software AG achieves SAP-certified integration with RISE with SAP S/4HANA Cloud, enhancing software asset management. Integration optimizes user licenses and maximizes value of SAP cloud investments USU Software AG Software Asset Management SAP Certification Cloud Integration RISE With SAP
PRESS RELEASE published on 08/06/2024 at 09:31, 1 year 8 months ago Original-Research: STINAG Stuttgart Invest AG (von GBC AG): Kaufen STINAG Stuttgart Invest AG: GBC AG stuft das Unternehmen positiv ein und empfiehlt Kauf mit Kursziel 26,00 EUR bis 31.12.2025. STINAG ist eine Immobilien-Holding mit diversifiziertem Portfolio in Süddeutschland Kaufempfehlung GBC AG Diversifizierung STINAG Stuttgart Invest AG Immobilien-Holding
PRESS RELEASE published on 08/06/2024 at 09:30, 1 year 8 months ago Advanced Blockchain AG announces new Management Board Team Advanced Blockchain AG announces new Management Board Team with Mr. Hatem Elsayed as COO and Mr. Maik Laske as incoming CFO, focusing on trust restoration. Investor update on August 8, 2024 Advanced Blockchain AG Investor Update Hatem Elsayed Management Board Team Maik Laske
PRESS RELEASE published on 08/06/2024 at 09:01, 1 year 8 months ago Original-Research: LAIQON AG (von NuWays AG): BUY LAIQON AG successfully places LAIC token 24 & intensifies cooperation with mVBRB, leading to total gross proceeds of €7.2m. Additional undisclosed payment to be invested in enhancing DAP 4.0 and personnel development Investments Coopération LAIQON AG LAIC Token MVBRB
PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 8 months ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG reports 35% sales increase to Euro 372 million in H1 2024. EBIT reaches Euro 78.4 million. FDA approves Yimmugo® and BNL facility. Positive revenue and earnings growth Revenue Growth FDA Approval Sales Increase Biotest AG H1 2024
PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 8 months ago Northern Data Group announces Q2 Results, reaffirms 2024 guidance Northern Data Group reports Q2 revenue growth of 22% year-on-year to EUR 26 million, reaffirms 2024 revenue target of EUR 200-240 million, driven by Cloud and HPC infrastructure expansion Revenue Growth Northern Data Group 2024 Guidance Q2 Results HPC Solutions
PRESS RELEASE published on 08/06/2024 at 08:31, 1 year 8 months ago Cherry SE Releases 2024 Half-Year Report Cherry SE releases its 2024 Half-Year Report, showing revenue growth in DIGITAL HEALTH & SOLUTIONS segment and confirmed forecasts for 2024 Revenue Growth Cherry SE Forecasts 2024 Half-Year Report DIGITAL HEALTH & SOLUTIONS
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant son avancement vers l'objectif de recrutement complet au premier trimestre 2025 Abivax Recrutement Essai Clinique Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant l'évolution favorable du projet. La société réaffirme ses prévisions pour 2025 Abivax Recrutement Traitement Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Abivax announces ABTECT Phase 3 Trial surpasses 600-patient enrollment milestone, on track for full enrollment by early Q1 2025. Trial trends align with previous observations Abivax Obefazimod Ulcerative Colitis ABTECT Phase 3 Trial Enrollment Milestone
Published on 04/22/2026 at 01:55, 8 hours 42 minutes ago Immutable Holdings Announces Director Resignation
Published on 04/22/2026 at 01:30, 9 hours 7 minutes ago Challenger West Assays Return Grades up to 60g/t Au
Published on 04/22/2026 at 00:00, 10 hours 37 minutes ago Zimtu Capital Corp. and Global Energy Metals Corporation Agree to Terminate Option Agreement for the Monument Peak Copper-Silver Project, Idaho
Published on 04/22/2026 at 00:00, 10 hours 37 minutes ago Grande Portage Resources Announces SEDAR+ Filing of Preliminary Economic Assessment (PEA) Study for the New Amalga Gold Project in SE Alaska
Published on 04/22/2026 at 10:18, 18 minutes ago Successful Listing on the Primary Market of Düsseldorf Stock Exchange Strengthens Capital Market Position and Growth Strategy
Published on 04/22/2026 at 09:35, 1 hour 1 minute ago Iconic British Brand Laura Ashley launches Four Fragrances Inspired by Archival Prints
Published on 04/22/2026 at 09:19, 1 hour 17 minutes ago EQS-Adhoc: TUI expects to report underlying EBIT for Q2 FY 2026 ahead of prior year, but adjusts FY 2026 underlying EBIT guidance at constant currency due to the continuing Iran war
Published on 04/22/2026 at 09:15, 1 hour 22 minutes ago Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.
Published on 04/22/2026 at 07:00, 3 hours 37 minutes ago Chiffre d'affaires 1er trimestre 2026. 229,5M€ à devises constantes. 215,5 M€ à devises courantes.
Published on 04/22/2026 at 07:00, 3 hours 37 minutes ago Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/21/2026 at 19:15, 15 hours 22 minutes ago AXA - Description of the Company’s share repurchase program
